about
Endocannabinoid system as a regulator of tumor cell malignancy - biological pathways and clinical significanceEndocannabinoids as Guardians of MetastasisG protein-coupled receptors as oncogenic signals in glioma: emerging therapeutic avenuesA lipid gate for the peripheral control of painKetoconazole inhibits the cellular uptake of anandamide via inhibition of FAAH at pharmacologically relevant concentrationsCB2 receptor activation inhibits melanoma cell transmigration through the blood-brain barrier.Anandamide inhibits breast tumor-induced angiogenesisColon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid.The alpha subunit of Go modulates cell proliferation and differentiation through interactions with Necdin.Perturbations of the endocannabinoid system in mantle cell lymphoma: correlations to clinical and pathological features.Association between cannabinoid CB₁ receptor expression and Akt signalling in prostate cancer.Expression and functional relevance of cannabinoid receptor 1 in Hodgkin lymphoma.Medicinal use of cannabis in Europe: the fact that more countries legalize the medicinal use of cannabis should not become an argument for unfettered and uncontrolled useCannabinoid receptor activation inhibits cell cycle progression by modulating 14-3-3β.Cannabinoids receptor type 2, CB2, expression correlates with human colon cancer progression and predicts patient survival.Cannabinoid receptor 1 promotes hepatocellular carcinoma initiation and progression through multiple mechanisms.Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cellsCannabinoid receptor signaling regulates liver development and metabolism.Antitumor effect of pyrrolo-1,5-benzoxazepine-15 and its synergistic effect with Oxaliplatin and 5-FU in colorectal cancer cellsLipid mediators involved in the oxidative stress and antioxidant defence of human lung cancer cells.CB1 and CB2 receptors are novel molecular targets for Tamoxifen and 4OH-Tamoxifen.Transcriptional Network Architecture of Breast Cancer Molecular SubtypesSelective Estrogen Receptor Modulators: Cannabinoid Receptor Inverse Agonists with Differential CB1 and CB2 Selectivity.Orphan nuclear receptor oestrogen-related receptor γ (ERRγ) plays a key role in hepatic cannabinoid receptor type 1-mediated induction of CYP7A1 gene expression.CB2 cannabinoid receptor activation promotes colon cancer progression via AKT/GSK3β signaling pathway.Downstream effects of endocannabinoid on blood cells: implications for health and disease.The evolving role of the endocannabinoid system in gynaecological cancer.Molecular mechanisms of target recognition by lipid GPCRs: relevance for cancer.Antitumorigenic targets of cannabinoids - current status and implications.Clinical Significance of Cannabinoid Receptors CB1 and CB2 Expression in Human Malignant and Benign Thyroid Lesions.Evaluation of cannabinoid CB1 and CB2 receptors expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients' survival.Novel analogs of PSNCBAM-1 as allosteric modulators of cannabinoid CB1 receptor.Anandamide drives cell cycle progression through CB1 receptors in a rat model of synchronized liver regeneration.Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System.
P2860
Q26739831-DBE3BA73-22DE-48C9-9A9E-D863D92CA90DQ26766163-D26907A7-820D-43C7-9F79-7438689D30AEQ26825769-A6FE7CBC-EE0F-4A27-BC27-7D4856B91BE0Q26995053-F03C7882-65F5-4739-80DD-B9AE77A4E9DCQ28539116-EF3AD0CA-865B-4BC2-B61A-16353B3FE45BQ33755702-B888000F-249A-48F4-9639-AC83B6656FE2Q34074335-68BBA846-AA94-40D0-9CCB-3D838640765CQ34441093-BAF612A5-9363-4CE4-87C3-E6E7AE0A7F46Q34485623-D768374F-5C93-4340-A4B0-79A9E74D6013Q34667539-DA6BBEF1-E1B7-49B9-B1A9-AF5A5115027FQ34766747-15DFDB8F-CB88-44F9-8E3E-85A225C81C9BQ35069709-A56CE62E-C5D8-49DB-B62B-94A012D18742Q35084518-41A50902-FA14-4098-AB8A-F18ABF7AF212Q35202838-C0984F03-23F6-4E4A-A041-D8179571561CQ35238992-024AB00C-072D-49EE-953F-5D5186DB5579Q35528377-1D7B9E75-BC6B-46DE-A070-A9AC459DA628Q36021048-B78D161F-0B07-4A45-9A02-6C99EABF1383Q36597443-84B4F7D4-5F38-42F6-94A8-ED2A2E4CAFF8Q37216913-F388C2F9-42B7-48BC-8967-801042761652Q37223268-7887728C-569E-4B61-BEAE-33FCA0AA1EC4Q37386840-EA594435-B988-4D95-A410-3B8ED4805EBAQ37428430-0FEBEC40-7B72-4057-B7D8-81E2F5C8B91EQ37525458-1D45A693-8A9C-47FA-B5F4-6748E5FC66BCQ37677097-8DF0203D-4A5D-4313-93A0-3595CF2CA1F7Q37708853-4B780BC0-AA66-45C4-821D-B26EF8766E63Q38468985-B8DB616B-15F6-492C-B46D-DCCE39C16C42Q38469671-A1FCCD3B-247E-48A6-B8F4-B93ADD7AD26EQ38660494-FBCDA076-58C3-4A75-B181-76FF8FFB57F2Q38806270-67C4D54A-705C-4521-B6E9-D971127FEDAFQ40353502-70AB2E7A-32B4-4847-AE1F-6BABEB6BAA86Q40440272-D719B80A-0CB9-4C30-8E66-46F683B61774Q47593740-8940A0BD-3E9D-4EB3-93A2-A11F05575500Q53615365-081FD79F-3FB2-40C3-9DF8-04F652DB2809Q55252194-732DAD61-45F6-44A6-9CB6-DBF0037A0EC9
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The endocannabinoid signaling system in cancer.
@en
type
label
The endocannabinoid signaling system in cancer.
@en
prefLabel
The endocannabinoid signaling system in cancer.
@en
P2093
P1476
The endocannabinoid signaling system in cancer.
@en
P2093
Alba D'Alessandro
Chiara Laezza
Paola Picardi
Simona Pisanti
P304
P356
10.1016/J.TIPS.2013.03.003
P577
2013-04-17T00:00:00Z